Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pulmonary Hypertension after Thalidomide Administration in Multiple Myeloma Patients. Pilot Study.

Christos Lafaras, PhD, Eudokia Mandala, PhD, Eugenia Verrou, MD, Dimitrios Platogiannis, PhD, Kostas Zervas, PhD, Theodoros Bischiniotis, PhD, George Ilonidis

Blood (2007) 110 (11): 4846.

https://doi.org/10.1182/blood.V110.11.4846.4846

Published: 2007

Journal Articles

Kinetics of Thrombin Generation in Patients with Multiple Myeloma.

Anna D. Petropoulou, MD, Grigoris T. Gerotziafas, MD, PhD, Kostas Zervas, A. Mpanti, MD, Michel Meyer Samama, Francine Rendu, PhD

Blood (2007) 110 (11): 3535.

https://doi.org/10.1182/blood.V110.11.3535.3535

Published: 2007

Journal Articles

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Evangelos Terpos, Meletios A. Dimopoulos, Charoula Xirakia, Dimitrios Christoulas, Athanasios Anagnostopoulos, Eirini Katodritou, Kostas Zervas, Paschalis Sideras, Konstantinos Tsionos, Evangelos Andreakos

Blood (2006) 108 (11): 3430.

https://doi.org/10.1182/blood.V108.11.3430.3430

Published: 2006

Journal Articles

Bortezomib Reduces Serum Dickkopf-1 and RANKL Concentrations and Normalizes Indices of Bone Remodeling in Patients with Relapsed Multiple Myeloma.

Evangelos Terpos, Deborah Heath, Amin Rahemtulla, Kostas Zervas, Andrew Chantry, Athanasios Anagnostopoulos, Anastasia Pouli, Eirini Katodritou, Evgenia Verrou, Elisavet C. Vervessou, Meletios A. Dimopoulos, Peter Croucher

Blood (2006) 108 (11): 506.

https://doi.org/10.1182/blood.V108.11.506.506

Published: 2006

Journal Articles

Evaluation of Traditional and Novel Predictive Markers of Anemia Response to Recombinant Human Erythropoietin (rh-Epo) in Patients with Multiple Myeloma and Lymphoma: Emerging Role of Functional Iron Deficiency.

Eirini Katodritou, MD, Matthaios Speletas, MD, Dimitris Kapetanos, MD, Kostas Zervas, MD, Aikaterini Pavlitou, MD, Elisabeth Georgiou, MD, Ioannis Korantzis, MD, Michael Sion, MD, John Christakis, MD

Blood (2004) 104 (11): 3690.

https://doi.org/10.1182/blood.V104.11.3690.3690

Published: 2004

NARROW

Pulmonary Hypertension after Thalidomide Administration in Multiple Myeloma Patients. Pilot Study.

Kinetics of Thrombin Generation in Patients with Multiple Myeloma.

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Bortezomib Reduces Serum Dickkopf-1 and RANKL Concentrations and Normalizes Indices of Bone Remodeling in Patients with Relapsed Multiple Myeloma.

Evaluation of Traditional and Novel Predictive Markers of Anemia Response to Recombinant Human Erythropoietin (rh-Epo) in Patients with Multiple Myeloma and Lymphoma: Emerging Role of Functional Iron Deficiency.

Email alerts

ASH Publications

American Society of Hematology

Pulmonary Hypertension after Thalidomide Administration in Multiple Myeloma Patients. Pilot Study.

Kinetics of Thrombin Generation in Patients with Multiple Myeloma.

Dysfunction of Toll-Like Receptor-2, −4, and −6: Is There a Role in the Pathogenesis of Immunodeficiency in Multiple Myeloma?.

Bortezomib Reduces Serum Dickkopf-1 and RANKL Concentrations and Normalizes Indices of Bone Remodeling in Patients with Relapsed Multiple Myeloma.

Evaluation of Traditional and Novel Predictive Markers of Anemia Response to Recombinant Human Erythropoietin (rh-Epo) in Patients with Multiple Myeloma and Lymphoma: Emerging Role of Functional Iron Deficiency.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only